Talat Imran
Chief Executive Officer, Director · Rani Therapeutics Holdings, Inc.
- 2024
- Sep 29, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Talat Imran files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- South Cone Investments Limited Partnership - $15.71M in RANI purchases and sales in the last 12 months
- Mir A. Imran - $1.29M in RANI purchases and sales in the last 12 months
- Alireza Javadi - $301 in RANI purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Talat Imran?
Talat Imran is a corporate insider, tracked as Chief Executive Officer, Director of Rani Therapeutics Holdings, Inc. (RANI). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Talat Imran submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Talat Imran been buying or selling stock?
Recorded transactions: 2 open-market purchases ($45K) and 0 open-market sales across all tracked filings.
